These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21702218)

  • 1. Islet-specific microRNAs in pancreas development, regeneration and diabetes.
    Joglekar MV; Parekh VS; Hardikar AA
    Indian J Exp Biol; 2011 Jun; 49(6):401-8. PubMed ID: 21702218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.
    Levetan C
    J Diabetes; 2010 Jun; 2(2):76-84. PubMed ID: 20923488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of islet-specific microRNAs during human pancreatic development.
    Joglekar MV; Joglekar VM; Hardikar AA
    Gene Expr Patterns; 2009 Feb; 9(2):109-13. PubMed ID: 18977315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular medicine of microRNAs: structure, function and implications for diabetes.
    Hennessy E; O'Driscoll L
    Expert Rev Mol Med; 2008 Aug; 10():e24. PubMed ID: 18702835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: promises and pitfalls.
    Locke JM; Harries LW
    Biochem Soc Trans; 2012 Aug; 40(4):800-3. PubMed ID: 22817737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes expressed in the developing endocrine pancreas and their importance for stem cell and diabetes research.
    Wells JM
    Diabetes Metab Res Rev; 2003; 19(3):191-201. PubMed ID: 12789652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pancreas from old: microregulators of pancreas regeneration.
    Joglekar MV; Parekh VS; Hardikar AA
    Trends Endocrinol Metab; 2007 Dec; 18(10):393-400. PubMed ID: 18023200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death.
    Hui H; Dotta F; Di Mario U; Perfetti R
    J Cell Physiol; 2004 Aug; 200(2):177-200. PubMed ID: 15174089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy.
    Sebastiani G; Vendrame F; Dotta F
    Transplant Proc; 2011; 43(1):330-2. PubMed ID: 21335216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production by islets in health and diabetes: cellular origin, regulation and function.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Halban PA; Ehses JA
    Trends Endocrinol Metab; 2010 May; 21(5):261-7. PubMed ID: 20096598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways to new beta cells.
    Zhou Q; Melton DA
    Cold Spring Harb Symp Quant Biol; 2008; 73():175-81. PubMed ID: 19478324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs and the regulation of glucose and lipid metabolism.
    Poy MN; Spranger M; Stoffel M
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():67-73. PubMed ID: 17919180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition.
    Zhao H; Guan J; Lee HM; Sui Y; He L; Siu JJ; Tse PP; Tong PC; Lai FM; Chan JC
    Pancreas; 2010 Aug; 39(6):843-6. PubMed ID: 20467341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration.
    Phillips JM; O'Reilly L; Bland C; Foulis AK; Cooke A
    Diabetes; 2007 Mar; 56(3):634-40. PubMed ID: 17327430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of MicroRNAs in Diabetes and Its Complications.
    Wu B; Miller D
    Methods Mol Biol; 2017; 1617():225-239. PubMed ID: 28540689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of pancreatic beta-cell regeneration.
    Khalaileh A; Gonen-Gross T; Magenheim J; Nir T; Porat S; Salpeter S; Stolovich-Rain M; Swisa A; Weinberg N; Dor Y
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():128-35. PubMed ID: 18834440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming into pancreatic endocrine cells based on developmental cues.
    Kordowich S; Mansouri A; Collombat P
    Mol Cell Endocrinol; 2010 Jul; 323(1):62-9. PubMed ID: 20025937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease.
    Brun T; Gauthier BR
    J Mol Endocrinol; 2008 Feb; 40(2):37-45. PubMed ID: 18234907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.